End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.41 CNY | -3.20% | +1.96% | -19.39% |
Apr. 25 | Hualan Biological Vaccine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Hualan Biological Vaccine Inc. Proposes Final Cash Dividend for 2023 | CI |
Sales 2024 * | 2.93B 406M | Sales 2025 * | 3.56B 493M | Capitalization | 13.45B 1.86B |
---|---|---|---|---|---|
Net income 2024 * | 1.04B 143M | Net income 2025 * | 1.28B 178M | EV / Sales 2024 * | 4.59 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
10.5
x | Employees | 770 |
Yield 2024 * |
3.17% | Yield 2025 * |
3.75% | Free-Float | 14.02% |
1 day | -3.20% | ||
1 week | +1.96% | ||
Current month | +1.96% | ||
1 month | -6.12% | ||
3 months | -4.84% | ||
6 months | -24.19% | ||
Current year | -19.39% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Jue An
CEO | Chief Executive Officer | 35 | 22-03-28 |
Cheng Yu Lü
DFI | Director of Finance/CFO | 43 | 20-05-31 |
Xiao Feng Cui
CTO | Chief Tech/Sci/R&D Officer | 49 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kang An
CHM | Chairman | 75 | 13-03-31 |
Bei Fan
BRD | Director/Board Member | 52 | 13-03-31 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 13-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 22.41 | -3.20% | 2,864,954 |
24-05-09 | 23.15 | +1.62% | 2,930,564 |
24-05-08 | 22.78 | +0.71% | 3,575,191 |
24-05-07 | 22.62 | +0.89% | 2,552,376 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.39% | 1.86B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 301207 Stock